News and Trends 14 Feb 2023
Minoryx Therapeutics announces X-linked adrenoleukodystrophy data
Minoryx Therapeutics has announced that data from its phase 2/3 ADVANCE clinical trial of lead candidate, leriglitazone, has been published…
Minoryx Therapeutics
- Latest Posts
More News! 14 Nov 2022
Minoryx and Neuraxpharm form alliance to get rights to new therapy for rare CNS disease
Minoryx Therapeutics and Neuraxpharm Group have announced a strategic alliance for the European rights to a new therapy for rare…
News and Trends 10 Nov 2022
Minoryx and Neuraxpharm announce license agreement to further X-ALD treatment
Minoryx Therapeutics and Neuraxpharm Group have announced the completion of a strategic license agreement. Minoryx is a biotech company that…
In Depth 8 Oct 2018
Behind the Scenes of the Spanish Biotech Industry’s Boom
The Spanish biotech industry is booming, but from my conversations with industry players elsewhere in Europe, it seems the country’s…
ADVERTISEMENT
News and Trends 26 Sep 2018
Spanish Biotech Raises €21.3M To Advance Rare Disease Pipeline
Rare genetic diseases in the central nervous system may be less of a headache in future, as Barcelona-based biotech Minoryx…
News and Trends 20 Feb 2018
A New Biotech Hopes to Bring Us the Next Generation of Rare Metabolic Disorder Drugs
Barcelona-based biotech, Minoryx, has spun out Gain Therapeutics to develop the next generation of drugs for rare metabolic disorders like GM1…
News and Trends 8 Jan 2018
And We’re Off! First Patient Dosed in this Spanish Biotech’s Rare Disease Trial
Minoryx Therapeutics has dosed the first patient in its Phase II/III trial for patients with adrenomyeloneuropathy, a condition that affects 1…
Interview 10 Jul 2017
Meet the CEO of Minoryx, the Spanish Biotech Fighting Rare Disease
I spoke with Marc Martinell, CEO of Minoryx, to learn first-hand how his company in Barcelona is bringing new hope…
News and Trends 21 Mar 2017
A Potential First Treatment for a Rare Genetic Disease clears Phase I
Minoryx Therapeutics has successfully completed a Phase I trial for its lead compound MIN-102 targeting X-linked adrenoleukodystrophy (X-ALD). The Spanish biotech Minoryx…
News and Trends 28 Feb 2017
It’s Global Rare Disease Day! What Cures is Biotech Cooking Up?
We've compiled a list of some of the latest advances of biotech in the field of rare disease to contribute…
ADVERTISEMENT
News and Trends 22 Feb 2017
Meet these 5 Awesome Biotechs from Barcelona at BIO Europe Spring 2017
As BIO Europe Spring 2017 approaches, we decided to take a closer look into biotechs from Barcelona, one of the hottest…
News and Trends 15 Oct 2015
Spanish connection: VC leads Biotech series A Fund to cure Rare Neurodegenerative Disease
Minoryx Therapeutics is a Barcelona based Rare-disease specialist who has a panel of orphan-drug experts for their discovery program. Now…
